Aberrant methylation in cancer.

R. Versteeg
1997-04-01
Abstract:Many lines of research point to a role for methylation in the control over growth and differentiation. Although aberrant methylation is widely suspected to play a part in tumorigenesis, this is firmly established for only a very few tumor types, because of our limited knowledge of the components of the cellular methylation machinery. During the past few years, some fascinating pieces of the methylation puzzle have been revealed. Studies of imprinted chromosomal regions have shed some light over the mechanism of spreading of methylation over large chromosomal regions. Studies of nonimprinted genes have provided insight into components of the methylation machinery that act in trans on target regions. Aberrant methylation profiles in human tumors can guide the search for defects in these methylation pathways. In this issue of the Journal, Maher and colleagues report on tumor-suppressor-gene methylation in tumors associated with the Von Hippel-Lindau (VHL) syndrome (Prowse et al. 1997 [in this issue]).
What problem does this paper attempt to address?